Process development of TRI-999, a fatty-acid-modified HIV fusion inhibitory peptide
Zhang, H., Schneider, S. E., Bray, B., Friedrich, P., Tvermoes, N., Mader, C., ... Wring, S. (2007). Process development of TRI-999, a fatty-acid-modified HIV fusion inhibitory peptide. Organic Process Research and Development, 12(1), 101 - 110.
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.